4.7 Article

A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Meta-analysis: Pharmacologic treatment of obesity

ZP Li et al.

ANNALS OF INTERNAL MEDICINE (2005)